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INTRODUCTION
MEDULLARY carcinoma is an uncommon tumour of the thyroid gland which
has been recognised only during the last 20 years. Between 1965 and 1978, 14
cases of medullary thyroid carcinoma have been diagnosed histologically in
Northern Ireland. The purposes of this paper are to document the relevant
details of these patients, to review the main clinical and pathological features of
medullary carcinoma of the thyroid and to discuss some aspects of investigation
and diagnosis of the condition.
CASE REPORTS
Five of the 14 cases referred to are described in some detail. Between them they
demonstrate many of the typical features of medullary carcinoma and its
associated phenomena. The main clinical aspects of all 14 cases are summarised
in Tables I and II.
TABLE I
Symptoms and signs in 14 patients with medullary carcinoma of the thyroid gland
Goitre Palpable
Nodes
Diarrhoea Other features
J.D. F 28 2 years Yes Yes Yes No
R.K. M 62 7 years Yes Yes No No
*F.O'N. M 65 Unknown Yes Yes No Squamous Carcinoma
lip
W.T. M 62 25 years Yes No No Left upper limb signs
and Homer's syn-
drome
E.U. F 40 6 months Yes No No No
M.P. F 51 1 month Yes No No No
M.Ra. F 55 15 months Yes No No Pain R. Neck
P.D. M 11 9 months Yes No No No
G.H. F 57 10 months Yes No No No
*N.I. F 59 Unknown Yes No No Pain left eye
M.Re. F 74 4 months Yes No No Weight loss
dysphagia
B.C. M 25 5 months No Yes No Marfanoidfeatures
mucosalneuromata
J.S. M 59 1 year Yes Yes Yes No
P.M. M 39 5 years No Yes Yes Hoarseness,
Marfanoid features
In these two patients the goitre was an incidental finding during admission for another reason.
The age and duration of symptoms refer to ti me of diagnosis.
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Patients Sex Age Duration of
symptoms
*CASE I (R.K.)
A 62 year old male was referred to hospital with two lumps on the right side of
his neck. The smaller swelling which had been present for six years was situated
in the right lobe of the thyroid gland. The larger mass lay in the posterior triangle
of the neck, partly covered by the stemomastoid muscle, and had appeared only
three months prior to attendance. A clinical diagnosis of carcinoma of the thyroid
with nodal metastases was made. Neck exploration was undertaken. A large hard
tumour nodule was found at the lower pole of the right lobe of the thyroid gland.
A clump of lymph nodes, obviously involved by tumour, was present at a higher
level, deep to the sternomastoid muscle. A total right lobectomy and block dis-
section of the right side of the neck was performed. Histological examination
revealed the presence of a primary medullary carcinoma of the thyroid with
metastatic disease in the cervical nodes. A course of radiotherapy to the neck was
given within eight weeks of surgery. Thyroxine was also prescribed in an attempt
to maintain thyroid suppression. The patient remained well until four years after
diagnosis, when he developed increasing weakness in both legs. A chest radiograph
showed a discrete circular mass in the left lower lobe, where a myelogram revealed
a complete block at the level of T9. Laminectomy was undertaken; the spinal
cord and dura were being compressed anteriorly by a large tumour mass at the
level of the radiological block. Palliative decompression was carried out. However,
the patient's condition deteriorated and he died four days later. Post mortem
examination revealed multiple metastases from the medullary thyroid carcinoma in
both lungs, the liver and around the region of the spinal cord decompression.
CASE 11 (F.O'N.)
A 65 year old man was referred from the Northern Ireland Radiotherapy Centre,
where he had been receiving treatment for carcinoma of the lower lip. Examination
had revealed the presence of multiple discrete lymph nodes on the right side of
the neck and in both supraclavicular fossae. There was no other significant sympto-
matology, but clinically the left lobe of the thyroid was enlarged and hard. Biopsy
of the neck glands suggested a diagnosis of secondary medullary carcinoma of the
thyroid. Formal exploration of the neck was undertaken. A large tumour in the
left lobe of the thyroid gland was found. There was widespread involvement by
tumour of the superficial and deep lymph nodes of the neck. A total left lobectomy
was carried out along with removal of all accessible lymph nodes. It was recognised
that a number of tumour nodes in the superior mediastinum were left behind. The
pathology report confirmed the thyroid tumour as being medullary carcinoma, the
malignant cells being dispersed in a matrix of amyloid. The postoperative course
was uneventful and the patient was discharged five days after surgery on 1-
thyroxine. He remained well for two years but then began to experience diarrhoea
which increased in intensity over a 12 month period. He developed hepatomegaly
and a liver scan confirmed the presence of multiple metastases. He died three and
a half years after diagnosis.
CASE III (P.D)
An 11 year old boy was referred to hospital because of a swelling in the left
anterior triangle of the neck which had been present for nine months. A clinical
diagnosis of adenoma of the left lobe of the thyroid gland was made. At operation
a 2 cm nodule was found in the left lobe of thyroid and a subtotal lobectomy
performed. The pathology report suggested that the lesion was a "well encapsulated
carcinoma". The patient was started on thyroxine as suppressant therapy. He
remained well but at review three and a half years later he was found to have a
swelling in the right lobe of his thyroid gland. At exploration this was seen to be
a well circumscribed nodule within the lobe and total lobectomy was carried out.
Histologically this nodule closely resembled that seen nearly four years earlier,
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following the demonstration of amyloid in the stroma. Further exploration of the
neck was undertaken when all remnants of the thyroid gland were removed. Nodules
of carcinoma comparable to the previous tumour were seen microscopically. In
the postoperative period tetany proved troublesome but gradually regressed with
the commencement of calcium therapy. The patient is now aged 17 years and is
alive and well six years after his initial operation, with no clinical evidence of
tumour. His calcitonin level, however, is elevated at 4.2 ng/ml (normal 0.08 ng/ml)
which may indicate the presence of residual recurrent disease.
CASE IV (B.C.)
A 25 year old male presented with a five mointh history of tiredness, lethargy
and general malaise. On examination he was noted to be tall and thin with
Marfanoid facies. Bilateral cervical and axillary lymphadenopathy were noted
but no goitre could be palpated. His lips were thickened and his tongue had a
serrated edge. He had attended the Plastic and Maxillo-Facial Unit eight years
earlier because of his facial appearance and poor dental condition. Dental clearance
and biopsy of 'nodular thickenings' of the tongue and lips had been carried out
at that time. Histological examination of the nodules had shown them to be
neuromata. Biopsy of the lymph nodes in the neck and the axillae was now per-
formed. Microscopically the cervical node was replaced by secondary medullary
thyroid carcinoma with large amounts of amyloid. The axillary nodes simply
demonstrated reactive change. Thyroid function tests, serum calcium and phos-
phorus levels were normal. However, the urinary levels of both catecholamines
and vannilyl mandelic acid (VMA) were grossly raised at 1742 ,ug/24 hours and
39 mg/24 hours respectively, the normal levels being less than 120 Ag/24 hours and
less than 9 mg/24 hours. An intravenous pyelogram demonstrated a normal urinary
tract. Nevertheless, on the basis of the urinary investigations the presence of a
phaeochromocytoma seemed certain. Confirmation of the diagnosis was achieved by
renal and adrenal aniography when a tumour of the left adrenal gland was identified.
Selective venous sampling revealed a forty-fold increase in catecholamine con-
centration in the blood draining from the left adrenal gland over that draining
from the right. In addition, the fasting plasma calcitonin level was now estimated
at 9.28 ng/,ml.
Abdominal exploration revealed not only a large 5 to 6 cm tumour of the
left adrenal gland but also a smaller phaeochromocytoma of the gland on the
right side. Bilateral subtotal adrenalectomy was carried out (Professor R. B.
Welbourn). Five weeks later total thyroidectomy was performed (Mr. S. Taylor).
Both lobes were diffusely infiltrated with medullary carcinoma tissue. A number
of lymph nodes, obviously involved in tumour, were also removed at operation
but formal block dissection of the neck was not attempted. Three parathyroid
glands were visualised and appeared normal macroscopically. Postoperatively,
steroid and thyroid replacement therapy was commenced and the patielnt pro-
gressed without major complication. A course of radiotherapy was given to the
neck three months following thyroidectomy because of persisting palpable lymph
nodes. At present, now more than three years since his surgery, he is in good
health and has returned to his former occupation as a merchant seaman. However,
although there is no clinical or radiological evidence of metastatic disease at present,
his plasma calcitonin levels have remained high, almost certainly indicating
continued presence of malignant tissue at some site, presumably in his neck.
CASE V (P.M.)
A 39 year old male was admitted to hospital for investigation of hoarseness which
had been present for six months. Systematic questioning revealed that for five years
he had been experiencing watery diarrhoea. He often passed 8 to 12 motions per
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Clinical details in 14 patients with medullary carcinoma in the thyroid gland
Patient Operation performed
J.D. Thyroid + node biopsy
R.K. R. total lobectomy
+ block dissection
F.O'N. L. total lobectomy
+ accessible nodes
W.T. L. total lobectomy
E.U. R. subtotal lobectomy
*M.P. R. subtotal lobectomy
M.Ra. Thyroid biopsy
P.D. L. subtotal lobectomy
R. total lobectomy
Total thyroidectomy
G.H. R. subtotal lobectomy
N.I. L. total lobectomy
M.Re. L. total lobectomy
tB.C. Total thyroidectomy
J.S. Thyroid + node biopsy
P.M. Node biopsy
R. total lobectomy
Node
metast-
asis
Yes
Current
status
Dead
Years
from
diagnosh
9
Yes Dead 4 2/12
Yes Dead 3 6/12
Persisting or
recurrent tumour
s
Radiological
metastases
Metastases at post
mortem +++
Hepatic metastases
Yes Dead 12 days Metastases at post
mortem +++
No Alive 9 Yes - mass in neck
No Dead Operative Multiple foci L lobe
Death at post mortem
No Dead 3 4/12 Mass in neck
No Alive 6 Only elevated
calcitonin level
No
No
No
Yes
Yes
Yes
Alive
Alive
Alive
Alive
Dead
Alive
5 10/12
3 9/12
3 8/12
3 6/12
No
No
No
Only elevated
calcitonin level
6/12 Mass in neck
11/12 Mass in neck
* The patient M.P. had a phaeochromocytoma of the right adrenal gland.
t The patient B.C. had bilateral phaeochromocytomata.
day, but at no time had he passed any blood per rectum. On examination he was
tall and thin. A firm diffuse mass was palpable in the lower neck on the right
side but was thought, clinically, not to be thyroid. Indirect laryngoscopy revealed
a paralysed right vocal cord. Surgical exploration of the cervical mass showed
it to be a cluster of matted malignant lymph nodes, several of which were removed
for biopsy. Microscopically the nodes were replaced by metastatic medullary
carcinoma of the thyroid gland. The plasma calcitonin level was grossly elevated
at 115.9 ng/ml.
Further operation was performed with a view to carrying out a block dis-
section of the neck along with thyroidectomy. A 1 cm diameter nodule was present
in the right lobe of the thyroid while the left lobe was quite normal. However,
there were many tumour nodes surrounding the carotid sheath on the right side
and extending deep into the neck. It was felt that these could not be removed
successfully and so right total lobectomy alone was carried out. Histology con-
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Calcitonin
estimation
(normal
0.08 ng/ml)
25 ng/ml
4.1 ng/ml
9.28 ng/ml
(pre-op)
6.56 ng/ml
(2yr post-op)
357 ng/ml
115.9 ng/ml
(
(firmed that the nodule in the right lobe was a primary medullary thyroid carci-
noma. In the 10 months since operation the patient's condition has remained fairly
stable. He continues to experience intermittent diarrhoea, while a hard nodular
mass persists on the right side of the neck. Plasma calcitonin levels remain very
high.
HISTORICAL ASPECTS
Medullary carcinoma of the thyroid gland was described as a distinct clinical
and pathological entity for the first time in 1959 (Hazard et al, 1959). It has
been estimated as constituting approximately 7 to 10 per cent of all thyroid
cancers (Hill et al, 1973) and as such is a relatively uncommon tumour. How-
ever, there is good evidence to suggest that it is a condition which has been
significantly underdiagnosed and misdiagnosed in the past (Normann et al, 1976).
Medullary carcinoma is a malignancy arising from the parafollicular or C-cells
of the thyroid gland. These cells are thought to derive from neural crest ectoderm
and to migrate at an early embryological stage into the primitive alimentary
tract mucosa from whence they are carried to their final resting place in the
thyroid, when this gland buds off the primitive foregut (Weichert, 1970). The
C-cells in the mature gland lie outside the follicles in a parafollicular distribution
and secrete the hormone calcitonin which plays a part in calcium homeostasis
by lowering the plasma calcium level (Ganong, 1977).
In recent years interest in medullary carcinoma of the thyroid has grown
significantly for a number of reasons. First, this type of tumour has shown itself
to be biologically extremely active by producing, in different instances, a
variety of hormones and enzymes including calcitonin and serotonin (Moertel,
1965; Williams, 1966), adrenocorticotrophic hormone (Scott, 1977), histaminase
(Baylin et al, 1970), and prostaglandins (Williams et al, 1968). Second, it has
been recognised that certain other endocrine anomalies may co-exist. Phaeoch-
romocytoma and parathyroid adenoma or hyperplasia are most frequently noted
and together with medullary thyroid carcinoma constitute the syndrome of
multiple endocrine neoplasia, type II or MEN II (Sipple, 1961; Williams, 1965;
Steiner et al, 1968). The patient (M.P.) who presented simply because of thyroid
enlargement was shown at post mortem examination to have a hitherto unsus-
pected phaeochromocytoma of her right adrenal gland. However, no parathyroid
abnormality was detected. A subgroup of patients exists (MEN IIb) in which
medullary thyroid carcinoma, alone or in association with the adrenal and
parathyroid lesions alluded to, is seen in the presence of multiple small neuro-
mata of the lips, tongue or eyelids, a high arched palate, Marfanoid facies and
occasionally other skeletal abnormalities. The patient (B.C.) is thought to fall
into this category.
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stimulus to increasing interest in the condition has been the recognition that in
a significant number of cases, medullary carcinoma of the thyroid has a strong
familial tendency (Melvin et al, 1972; Jackson et al, 1973; Sizemore et al, 1977).
It is now thought probable that in affected families inheritance is on an auto-
somal dominant basis. Thus, about 50 per cent of the offspring of a patient
known to have medullary carcinoma might be expected to develop the disease.
This obviously has extremely important implications in terms of investigation
and follow-up of 'at risk' family members.
PATHOLOGICAL CONSIDERATIONS
Hazard and his co-authors described the characteristic histological pattern of
medullary thyroid carcinoma as consisting of solid sheets and cords of spindle
shaped or polyhedral cells, broken up by a stroma containing amyloid (Hazard
et al, 1959). They emphasise the importance of the absence of any tendency
towards papillary or follicular formation. Amyloid was present in easily recog-
nisable quantities in the stroma in all 21 cases described by Hazard and his
colleagues, and they imply that the presence of amyloid is necessary for a
diagnosis of medullary carcinoma to be made. Other pathologists have largely
agreed with this view (Woolner et al, 1961; Williams et al, 1966), although
Williams and his colleagues in their detailed studies of the pathological findings
in medullary carcinoma, while excluding three cases from their review on the
grounds that no amyloid could be identified microscopically, state that the
absence of amyloid should not necessarily exclude the diagnosis of medullary
carcinoma (Williams et al, 1966). This view has more recently been expressed
with more conviction following the discovery that in some instances, although
amyloid cannot be identified using the light microscope in what was thought
to be a medullary carcinoma, electron microscopy reveals the presence of typical
calcitonin secretory granules in the tumour cells (Normann et al, 1976). In all
14 cases reported here amyloid was identified histologically in the tumours.
Electron microscopy was performed in only one instance (patient P.M.) where
moderate numbers of densely staining secretory granules were visualised within
the neoplastic C-cells.
CLINICAL FEATURES
Medullary thyroid carcinoma is less common in females relative to males than
other thyroid cancers, resulting in a virtually equal sex incidence (Shapiro, 1976;
Sizemore et al, 1977). Of these 14 cases, seven are male and seven female.
Clinically the patient most commonly presents with a goitre or because of cervical
lymphadenopathy. It can be seen that the majority of our patients (12 out of
14) had a palpable goitre at the time of presentation. Six patients, of whom two
had no goitre, demonstrated cervical lymphadenopathy at initial examination
(Table I). Less frequently diarrhoea may be the major presenting feature. The
cause of the diarrhoea in such patients remains unknown although a number of
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different agents, including calcitonin itself, serotonin and the prostaglandins E2
and F2 C (Williams et al, 1968; Bernier et al, 1969; Steinfield et al, 1973). Diarrhoea
seems to be more prevalent in those patients who have extensive local disease or
disseminated tumour and would, therefore, appear to be related to tumour bulk
(Williams, 1966). This suggestion would be in keeping with the findings in our
own group of patients, three of whom were experiencing diarrhoea at the time
of presentation (Table I). A fourth patient (F.O'N.) developed severe diarrhoea
approximately two years after he had been diagnosed, and this persisted until
his death from hepatic metastases.
Occasionally, the presenting symptomatology may be related to associated
pathology, particularly phaeochromocytoma, or to metastatic disease. The
importance of excluding co-existing phaeochromocytoma in a patient with
medullary carcinoma before embarking on thyroid surgery cannot be over-
emphasised. The patient (M.P.) in the perioperative and immediate postoperative
periods developed a series of unexplained cardiac arrhythmias and hypertension
which resulted in acute cardiac failure and death. The latter was almost certainly
due to excess circulating levels of catecholamines released from a phaeochromo-
cytoma of the right adrenal gland, unsuspected clinically but discovered at post
mortem examination.
The malignancy of medullary thyroid carcinoma is thought to be of inter-
mediate grade, but while in some patients the presence of the tumour is
compatible with good life expectancy, others die rapidly from widespread
metastatic disease. This variation is reflected in our own series in which the
survival time following diagnosis ranged from six months to nine years, if the
two patients who died in the immediate postoperative period are excluded
(Table II). Hill and his colleagues (1973) report a crude overall five year survival
after diagnosis of 37 out of 72 cases (51 per cent). The corresponding 10 year
survival rate is 29 per cent. The best prognosis is associated with complete
surgical removal of the tumour.
DIAGNOSIS
Diagnosis of medullary carcinoma of the thyroid gland was, until comparatively
recently, essentially a postoperative one, based on histological examination of
the surgical specimen. However, in the late sixties it was recognised by a number
of workers, including Cunliffe and his colleagues in Newcastle, that a hypo-
calcaemic agent was present in the plasma of patients with medullary carcinoma
and also in the tumour itself (Cunliffe et al, 1968). The Newcastle group pro-
vided convincing evidence that this was calcitonin, elevated levels of which were
identified in the plasma of their patient preoperatively. Further, all hypo-
calcaemic activity and detectable calcitonin disappeared from the circulation
within hours of total thyroidectomy. It was, therefore, suggested that medullary
carcinoma of the thyroid did in fact produce calcitonin and could be diagnosed
preoperatively by measuring plasma calcitonin levels. It was also suggested that,
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metastases might be detected at an early stage (Cunliffe et al, 1968). These hypo-
theses have subsequently been shown to be correct (Deftos and Potts, 1970;
Melvin et al, 1971; Deftos, 1974). Although elevated plasma levels of calcitonin
have been demonstrated in a number of patients (Table II), these estimations
were all carried out after the diagnosis of medullary carcinoma had been made
histologically. As indicated in Table II, three patients had clinically evident
disease at the time of the calcitonin measurement, while two others were free
a palpable tumour. It remains to be seen how these latter two patients progress.
One problem has been the fact that the radioimmunoassay necessary to measure
plasma and tissue calcitonin levels is available in only a very few centres.
However, such an assay is now being established in the University Department
of Medicine, Belfast.
Since 1965 only the 14 cases of medullary thyroid carcinoma reported here
have been positively diagnosed in Northern Ireland. It is, however, likely that
during the past 25 years there have been other cases misdiagnosed, the clinicians
and pathologists perhaps being unaware of the existence of the entity.
FUTURE MANAGEMENT
Medullary carcinoma of the thyroid gland while usually presenting in a sporadic
manner, reveals a strong familial tendency. The more enthusiastically this familial
tendency is sought, the more often it is found. Sizemore and his colleagues
(1977) in a recent review of a five year experience of medullary carcinoma at
the Mayo Clinic, suggest that at least 19 per cent of patients assumed to be
suffering from the sporadic variant, in fact have familial disease. It would,
therefore, seem to be extremely important to investigate 'at risk' first degree
relatives of patients who have been identified as having medullary thyroid carci-
noma. The main object of this is to identify those carrying the disease at as early
a stage as possible so that appropriate treatment in the form of total thyroid-
ectomy can be instituted. Basal plasma calcitonin levels in such patients may,
however, be totally normal.
In recent years, however, it has been shown that the hyperplastic or neoplastic
C-cell mass can be provoked or stimulated into producing elevated plasma
levels of calcitonin by a number of different agents (Hennessy et al, 1973;
Cohen et al, 1973). Calcium, pentagastrin, alcohol and glucagon are among those
which have been utilised in different centres and with varying degrees of efficacy
in calcitonin provocation tests (Hennessy et al, 1974; Wells et al, 1975; Sizemore
and Go, 1975; Dymling et al, 1976). Patients with medullary carcinoma show an
elevation in their plasma calcitonin level following administration of one or
more of these agents while normal individuals fail to demonstrate any change.
Several centres have now reported the use of calcitonin provocation tests in the
investigation of appropriate patients who are at risk, in an attempt to diagnose
preclinical, occult medullary thyroid carcinoma (Telenius-Berg et al, 1977; Starling et al, 1978; Hillyard et al, 1978; Lips et al, 1978). In many instances an
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tration of a reliable provocative agent has been accepted as the only criterion
necessary to proceed to neck exploration. When this policy has been adopted
it has now been clearly shown that in virtually 100 per cent of patients whose
necks have been explored, and in whom total thyroidectomy has been performed,
medullary carcinoma or its precursor state C-cell hyperplasia has been found
(Wolfe et al, 1973; Wells et al, 1975; Leape et al, 1976; Verdy et al, 1978; Wells
et al, 1978).
The importance of early operation before the tumour has extended locally
or metastasized is obvious. Availability of a reliable provocation test coupled
with an aggressive surgical approach in appropriate cases should allow for some
improvement in the prognosis for these early cases. Follow-up of patients
operated on for occult, asymptomatic medullary thyroid carcinoma is still very
limited (less than five years in most instances). However, early results would
suggest that total thyroidectomy has been 'curative', as judged by negative
postoperative provocation tests, in more than 80 per cent of patients whose
diagnosis was made on the basis of provocative testing alone (Wells et al, 1978).
Encouraged by these results, active provocative testing of the first degree
relatives of patients in Northern Ireland known to have had medullary carci-
noma has now commenced. Other index cases and their families have yet to
be traced. Only time will reveal the relevance of the exercise.
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